Form 4: Relay Therapeutics CEO Sells Shares
Insider Transaction (Form 4)
Sanjiv Patel, President and CEO and a Director of Relay Therapeutics, Inc., sold 48,199 shares of common stock on August 17, 2026 for $20.33 per share.
Summary
- Open-market sale: disposed of 48,199 Common Stock at $20.33 ($979,886) on August 17, 2026; holds 567,699 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $979,886 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Sanjiv Patel — Director, Officer (President and CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-17 | Open-market sale | Common Stock | 48,199 | $20 | $979.9K | 567,699 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-17 | Open-market sale (48,199 shares) |
Keywords
insider transaction, Form 4, RLAY, Relay Therapeutics, Inc., bearish, Sanjiv Patel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.